Harrison Nathan J, Dodd Rachael H, Sharman Ashleigh R, Marshall Henry M, Stone Emily, Rhee Joel J, Yap Mei Ling, McCullough Sue, Paul Christine, Bowden Jacqueline A, Bonevski Billie, Rankin Nicole M
Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame, School of Public Health, The University of Queensland, Herston, QLD, Australia.
Nicotine Tob Res. 2025 Feb 24;27(3):387-397. doi: 10.1093/ntr/ntae215.
Lung cancer screening (LCS) trials, targeting people with a smoking history, have demonstrated reduced mortality. How to optimally embed evidence-based smoking cessation support in LCS, including in Australia, needs to be better understood. We sought experts' perspectives to identify potential barriers and effective implementation strategies.
Perceptions of providing smoking cessation support in LCS were elicited in 24 focus groups and three individual interviews with clinicians, cancer screening program managers/policymakers, and researchers during 2021. We conducted framework analysis and mapped key topics to the updated Consolidated Framework for Implementation Research (CFIR).
Experts (N = 84 participants) strongly supported capitalizing on an "opportune time" for smoking cessation and new LCS participant contact opportunities throughout the screening and assessment pathway. Many advocated for adapting existing cessation resources to the LCS setting and providing support without participant costs. Experts generally considered referral alone to established programs (eg, telephone Quitline) as insufficient, but likely helpful in follow-up, and dedicated cessation specialist roles as essential. Broader cessation messaging (via mass media/community channels) was also suggested to reinforce individualized support. Experts described inherent alignment, and an ethical responsibility, to deliver smoking cessation as a core LCS component. It was suggested that LCS-eligible participants' varied experiences of stigma, health literacy, and motivation, be considered in cessation support. Primary care support and individualized interventions were suggested to facilitate implementation.
Experts considered smoking cessation support essential in LCS. The expert-identified and multi-level implementation strategies described here can directly inform smoking cessation-specific planning for Australia's forthcoming National LCS Program.
The international literature includes few examples considering how best to provide smoking cessation support within a LCS program in advance of program commencement. Our analysis, using the updated CFIR, is one of the first to explore experts' perspectives within this context. Experts identified multiple implementation barriers to providing smoking cessation support within and outside of an Australian LCS program, including key work infrastructure barriers, and advocated for providing tailored interventions within this program. Our foundational work in a new targeted screening program's preimplementation phase will allow international comparisons to be made.
针对有吸烟史人群的肺癌筛查(LCS)试验已证明可降低死亡率。如何在LCS中,包括在澳大利亚,最佳地融入基于证据的戒烟支持,仍需更好地理解。我们寻求专家的观点,以确定潜在障碍和有效的实施策略。
2021年期间,通过24个焦点小组以及对临床医生、癌症筛查项目管理人员/政策制定者和研究人员进行的三次个人访谈,了解了在LCS中提供戒烟支持的看法。我们进行了框架分析,并将关键主题映射到更新后的实施研究综合框架(CFIR)。
专家(N = 84名参与者)强烈支持在整个筛查和评估过程中,利用戒烟的“适当时机”以及与新的LCS参与者接触的机会。许多人主张使现有的戒烟资源适应LCS环境,并在不向参与者收费的情况下提供支持。专家们普遍认为,仅将患者转介到既定项目(如电话戒烟热线)是不够的,但可能对后续跟进有帮助,并且认为设立专门的戒烟专家职位至关重要。还建议通过大众媒体/社区渠道进行更广泛的戒烟宣传,以加强个性化支持。专家们描述了将戒烟作为LCS核心组成部分的内在一致性和道德责任。建议在戒烟支持中考虑符合LCS条件的参与者在耻辱感、健康素养和动机方面的不同经历。建议提供初级保健支持和个性化干预措施以促进实施。
专家们认为戒烟支持在LCS中至关重要。这里描述的由专家确定的多层次实施策略可以直接为澳大利亚即将推出的国家LCS计划中针对戒烟的具体规划提供参考。
国际文献中很少有在项目启动前考虑如何在LCS项目中最佳地提供戒烟支持的例子。我们使用更新后的CFIR进行的分析是在此背景下最早探索专家观点的分析之一。专家们确定了在澳大利亚LCS项目内外提供戒烟支持的多个实施障碍,包括关键的工作基础设施障碍,并主张在该项目中提供量身定制的干预措施。我们在新的目标筛查项目实施前阶段所做的基础工作将便于进行国际比较。